625 related articles for article (PubMed ID: 25481511)
21. Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer.
Li L; Zhang L; Zhang Y; Zhou F
Biomed Pharmacother; 2015 May; 72():109-12. PubMed ID: 26054683
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer.
Peng W; Gao W; Feng J
Med Oncol; 2014 Dec; 31(12):346. PubMed ID: 25412939
[TBL] [Abstract][Full Text] [Related]
24. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
25. Correlation of increased MALAT1 expression with pathological features and prognosis in cancer patients: a meta-analysis.
Shi XS; Li J; Yang RH; Zhao GR; Zhou HP; Zeng WX; Zhou M
Genet Mol Res; 2015 Dec; 14(4):18808-19. PubMed ID: 26782531
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.
Zhou B; Jing XY; Wu JQ; Xi HF; Lu GJ
Int J Clin Exp Pathol; 2014; 7(12):8893-8. PubMed ID: 25674261
[TBL] [Abstract][Full Text] [Related]
27. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis.
Zhang J; Zhang B; Wang T; Wang H
Int J Clin Exp Med; 2015; 8(4):5499-505. PubMed ID: 26131129
[TBL] [Abstract][Full Text] [Related]
29. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer.
Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419
[TBL] [Abstract][Full Text] [Related]
30. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer.
Chen P; Wan D; Zheng D; Zheng Q; Wu F; Zhi Q
Biomed Pharmacother; 2016 Oct; 83():1220-1226. PubMed ID: 27562722
[TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy.
Li L; Chen H; Gao Y; Wang YW; Zhang GQ; Pan SH; Ji L; Kong R; Wang G; Jia YH; Bai XW; Sun B
Mol Cancer Ther; 2016 Sep; 15(9):2232-43. PubMed ID: 27371730
[TBL] [Abstract][Full Text] [Related]
33. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
[TBL] [Abstract][Full Text] [Related]
34. [Expression of LncRNA AK09398 and Relationship with Prognosis in Patients with Small Cell Lung Cancer].
Liu B; Liu X; Yang Y; Ge J; Li J
Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):754-759. PubMed ID: 27866518
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
36. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
[TBL] [Abstract][Full Text] [Related]
38. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
40. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
